Hypothyroidism and Injection site extravasation

Summary:

Injection site extravasation is found among people with Hypothyroidism, especially for people who are female, 60+ old.

The study analyzes which people have Injection site extravasation with Hypothyroidism. It is created by eHealthMe based on reports of 70 people who have Hypothyroidism from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypothyroidism?

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development) is found to be associated with 1,616 drugs and 2,600 conditions by eHealthMe. Check the latest studies of Hypothyroidism.

What is Injection site extravasation?

Injection site extravasation (flow of (blood or lymph) from injection site) is found to be associated with 555 drugs and 728 conditions by eHealthMe. Check the latest studies of Injection site extravasation.

On Jul, 28, 2026

70 people who have Hypothyroidism and Injection Site Extravasation are studied.

Would you have Injection site extravasation when you have Hypothyroidism?

Gender of people who have Hypothyroidism and experienced Injection Site Extravasation *:

female: 84.29 %
male: 15.71 %

Age of people who have Hypothyroidism and experienced Injection Site Extravasation *:

Common co-existing conditions for these people *:

High Blood Cholesterol: 24 people, 34.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 23 people, 32.86%
High Blood Pressure: 17 people, 24.29%
Depression: 17 people, 24.29%
Type 2 Diabetes: 15 people, 21.43%
Diabetes: 11 people, 15.71%
Psoriasis (immune-mediated disease that affects the skin): 9 people, 12.86%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 8 people, 11.43%
Hypersensitivity: 8 people, 11.43%
Stress And Anxiety: 7 people, 10.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Injection Site Pain: 21 people, 30.00%
Injection Site Haemorrhage (bleeding from injection site): 12 people, 17.14%
Fatigue (feeling of tiredness): 6 people, 8.57%
Injection Site Bruising: 5 people, 7.14%
Weight Decreased: 4 people, 5.71%
Injection Site Irritation: 3 people, 4.29%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 4.29%
Joint Pain: 3 people, 4.29%
Headache (pain in head): 3 people, 4.29%
Pain In Extremity: 3 people, 4.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Injection site extravasation?

- Check whether Injection site extravasation is associated with a drug or a condition

Related publications that referenced our studies

Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Injection site extravasation and Hypothyroidism, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.